Dirk Winkler
Impact in
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Co-authors
- Stephan StilgenbauerHartmut DöhnerAndreas BühlerKai HilpertRobert E. W. HancockThorsten ZenzMichael HallekRaymonde Busch
- Journals
- Blood (31 papers)SLAS DISCOVERY (6 papers)Journal of Clinical Oncology (5 papers)min - Minimally Invasive Neurosurgery (5 papers)Computer Aided Surgery (4 papers)
- Partner nations
- GermanyCanadaUnited States
In The Last Decade
Dirk Winkler
160 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 146
- Genetics 2.3k
- Pathology and Forensic Medicine 1.8k
- Microbiology 377
- Immunology 1.0k
- Hematology 398
Countries citing papers authored by Dirk Winkler
This map shows the geographic impact of Dirk Winkler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Winkler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Winkler more than expected).
Fields of papers citing papers by Dirk Winkler
This network shows the impact of papers produced by Dirk Winkler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Winkler. The network helps show where Dirk Winkler may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Winkler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 14 | |
| 12 | 2018 | 8 | |
| 13 | 2015 | 6 | |
| 14 | 2015 | 24 | |
| 15 | 2009 | 45 | |
| 16 | 2008 | 9 | |
| 17 | 2007 | 225 | |
| 18 | 2006 | 29 | |
| 19 | Efficacy of subcutaneous Alemtuzumab (Campath-1H) in genetic high-risk, fludarabine-refractory CLL: CLL2H study of the German CLL Study Group (GCLLSG) | 2005 | 18 |
| 20 | 2001 | 16 |
About Dirk Winkler
Dirk Winkler is a scholar working on Genetics, Neurology, Pathology and Forensic Medicine, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 168 papers that have together received 4.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (48 papers), Lymphoma Diagnosis and Treatment (25 papers), Immunodeficiency and Autoimmune Disorders (18 papers), Neurological disorders and treatments (16 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Chemical Synthesis and Analysis (12 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Glioma Diagnosis and Treatment (10 papers). The work is most often cited by research in Genetics (2.3k citations), Pathology and Forensic Medicine (1.8k citations), Microbiology (377 citations), Immunology (1.0k citations) and Hematology (398 citations). Dirk Winkler has collaborated with scholars based in Germany, Canada and United States. Frequent co-authors include Stephan Stilgenbauer, Hartmut Döhner, Andreas Bühler, Kai Hilpert, Robert E. W. Hancock, Thorsten Zenz, Michael Hallek, Raymonde Busch, Sonja Häbe and Jürgen Meixensberger. Their work appears in journals such as Blood, SLAS DISCOVERY, Journal of Clinical Oncology, min - Minimally Invasive Neurosurgery and Computer Aided Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.